Welcome to LookChem.com Sign In|Join Free

CAS

  • or

130111-08-9

Post Buying Request

130111-08-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

130111-08-9 Usage

Description

3-(BENZYLOXY)-2-HYDROXYPROPANOIC ACID, also known as (R)-3-(Benzyloxy)-2-hydroxypropanoic Acid, is an organic compound with the molecular formula C10H12O4. It is a derivative of hydroxypropanoic acid, featuring a benzyloxy group attached to the third carbon and a hydroxyl group on the second carbon. 3-(BENZYLOXY)-2-HYDROXYPROPANOIC ACID is known for its potential applications in various industries due to its unique structural properties.

Uses

Used in Pharmaceutical Industry:
3-(BENZYLOXY)-2-HYDROXYPROPANOIC ACID is used as a reactant for the synthetic preparation of 2-Oxopiperazine derivatives, which are important in the development of pharmaceutical compounds. The application reason is that these derivatives have shown potential in various therapeutic areas, including the treatment of central nervous system disorders, cardiovascular diseases, and certain types of cancer.
Used in Chemical Synthesis:
In the field of chemical synthesis, 3-(BENZYLOXY)-2-HYDROXYPROPANOIC ACID serves as a versatile building block for the creation of more complex molecules. The application reason is its unique structural features, which allow for further functionalization and the formation of a wide range of compounds with diverse properties and potential applications.
Used in Research and Development:
3-(BENZYLOXY)-2-HYDROXYPROPANOIC ACID is also used as a research compound in academic and industrial laboratories. The application reason is to explore its chemical properties, reactivity, and potential applications in various fields, such as materials science, pharmaceuticals, and agrochemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 130111-08-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,1,1 and 1 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 130111-08:
(8*1)+(7*3)+(6*0)+(5*1)+(4*1)+(3*1)+(2*0)+(1*8)=49
49 % 10 = 9
So 130111-08-9 is a valid CAS Registry Number.

130111-08-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name HO-Ser(Bn)-OH

1.2 Other means of identification

Product number -
Other names (2S)-3-bezyloxy-2-hidroxy propanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:130111-08-9 SDS

130111-08-9Relevant articles and documents

PROTEIN TYROSINE PHOSPHATASE DEGRADERS AND METHODS OF USE THEREOF

-

Page/Page column 491, (2021/06/26)

Provided herein are compounds, compositions, and methods useful for degrading protein tyrosine phosphatase, e.g., protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases favorably responsive to PTPN1 or PTPN2 inhibitor treatment, e.g., a cancer 5 or a metabolic disease.

Total Synthesis of the Cyclic Depsipeptide Vioprolide D via its (Z)-Diastereoisomer

Bach, Thorsten,Grab, Hanusch A.,Kirsch, Volker C.,Sieber, Stephan A.

supporting information, p. 12357 - 12361 (2020/05/05)

The first total synthesis of vioprolide D was accomplished in an overall yield of 2.0 % starting from methyl (2S)-3-benzyloxy-2-hydroxypropanoate (16 steps in the longest linear sequence). The cyclic depsipeptide was assembled from two building blocks of

JAK1 SELECTIVE INHIBITORS

-

Page/Page column 64; 65, (2018/08/12)

Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein R1-R8 have any of the meanings defined herein. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of using the same.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 130111-08-9